Circulating Tumor Cells Market to Surpass US$ 19.0 Billion by 2032 as Liquid Biopsy Adoption Expands Says Astute Analytica

Driven by rising cancer prevalence, rapid adoption of liquid biopsies, and breakthroughs in single-cell analysis, the global ...